Collaboration at PFICELL

At PFICELL, we believe that global collaboration is the cornerstone of innovation and access. Our model spans clinical, technological, and academic domains—designed to empower partners worldwide in delivering cell therapies with confidence.

Clinical Joint Ventures

• Patient identification and referral frameworks

• Standardizing Tumor Board Review protocols

• Building integrated clinical-laboratory ecosystems

• Launching shared immunotherapy and regenerative medicine programs

Technology Transfer & Licensing

• CAR-T cell platforms

• Gamma Delta T cell expansion kits

• iPSC-derived neural and immune lineages

• NK and TIL protocols

These partnerships include training, documentation, and ongoing support.

Contract Manufacturing & CDMO Services

• Cell therapy products (clinical and commercial-grade)

• Custom-engineered cell models

• Personalized regenerative formulations

Global Patient Access Programs

• Cross-border care coordination

• Relocation support for patients and families

• Mobile clinical units and remote diagnostics

• Comprehensive immunological profiling and personalized planning

Academic & Scientific Collaboration

• Joint research and co-authored publications

• Exchange programs for fellows, clinicians, and scientists

• Symposia and workshops

• Collaborative grants and innovation consortia

We invite clinical centers, biotech innovators, academic institutions, and research networks to explore strategic collaboration opportunities with PFICELL.
Contact us to begin the conversation.